---
document_datetime: 2024-05-21 13:35:51
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/mysildecard-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: mysildecard-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 2.7462302
conversion_datetime: 2025-12-26 17:16:56.669744
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Mysildecard

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IA/0014              | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure | 24/05/2023                          | n/a                                         |                                  |           |
| IB/0013              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following               | 30/11/2022                          | 29/06/2023                                  | SmPC                             |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                  |            |            |                        |                                                                                                                                                                                                                                                                           |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0012   | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation | 01/07/2022 | 29/06/2023 | SmPC and PL            | To update section 4.5 of the SmPC to add a warning about the increase in hypotension observed with concomitant use of sildenafil and sacubitril/valsartan. The Package leaflet is updated accordingly.                                                                    |
| IB/0011   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                  | 03/06/2022 | n/a        |                        |                                                                                                                                                                                                                                                                           |
| T/0010    | Transfer of Marketing Authorisation                                                                                                                                                            | 07/10/2021 | 28/10/2021 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                           |
| R/0009    | Renewal of the marketing authorisation.                                                                                                                                                        | 20/05/2021 | 16/07/2021 | SmPC, Annex II and PL  | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Mysildecard in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| N/0008    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                               | 14/01/2021 | 16/07/2021 | PL                     |                                                                                                                                                                                                                                                                           |
| IA/0007/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.III.1.a.2 - Submission of a new/updated or                                  | 17/11/2020 | n/a        |                        |                                                                                                                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

|         | of Ph. Eur. Certificate of Suitability to the Ph. Eur. Monograph - Updated certificate an already approved manufacturer                                                                                                                                      |            |            |                  | deletion relevant from   |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------|--------------------------|
| IB/0006 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 04/11/2020 | 16/07/2021 | SmPC and PL      |                          |
|         | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                       | 30/04/2020 | 25/06/2020 | Annex II and PL  | IAIN/0005                |
| IB/0004 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 09/07/2019 | 25/06/2020 | SmPC and PL      |                          |
| IA/0003 | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                  | 25/03/2019 | n/a        |                  |                          |
| N/0002  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                             | 22/03/2019 | 25/06/2020 | Labelling and PL |                          |

<div style=\"page-break-after: always\"></div>

| IAIN/0001/G   | This was an application for a group of variations.   | 16/03/2017   | n/a   |
|---------------|------------------------------------------------------|--------------|-------|